Chinese Journal of Pharmaceuticals, Volume. 56, Issue 7, 871(2025)

Synthesis and Purification of Related Substances of Voclosporin

MAI Zidan1, JIANG Bibo2, LIU Jiajia2, XU Shengjun3, ZHANG Fuli2, and ZHAO Chuanmeng2、*
Author Affiliations
  • 1College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201203
  • 2Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
  • 3Boxiao (Hangzhou) Biopharmaceutical Co., Ltd., Hangzhou 311404
  • show less

    Herein two related substances (A and B) of voclosporin (1) were prepared and purified. Compound B was Z-isomer of 1, named cyclo-[[(6Z)-(2S, 3R, 4R)-3-hydroxy-4-methyl-2-(methylamino)-6, 8-nonadienoyl]-L-2-aminobutyryl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl]. E configuration of acetylated voclosporin (5) was transferred into related substance B via configuration conversion and acetyl group removal under triethylamine/lithium bromide with high-purity, which was reported at the first time. In addition, in the process optimization of 1, the over-oxidized impurity, related substance A was found and prepared for the first time. Its structure was confirmed as acetylated cyclosporine A acid by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. The above two compounds can be served as the references for the quality control of 1.

    Tools

    Get Citation

    Copy Citation Text

    MAI Zidan, JIANG Bibo, LIU Jiajia, XU Shengjun, ZHANG Fuli, ZHAO Chuanmeng. Synthesis and Purification of Related Substances of Voclosporin[J]. Chinese Journal of Pharmaceuticals, 2025, 56(7): 871

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Dec. 31, 2024

    Accepted: Aug. 26, 2025

    Published Online: Aug. 26, 2025

    The Author Email: ZHAO Chuanmeng (hotcmeng@163.com)

    DOI:10.16522/j.cnki.cjph.2025.07.005

    Topics